Genomic DNA purified from peripheral blood samples from 26 patients with MPN, diagnosed at Shiga Medical Center for Adults in 2008 and 2009, was analyzed to determine JAK2 V617F mutation status. This evidence concerns the gene JAK2 and myeloproliferative disorder.